[ad_1] For all the attention paid to the highflying tech giants dubbed the Magnificent Seven,…
CH:NOVN
-
-
STOCK MARKET
Novartis to bolster its oncology portfolio with acquisition of MorphoSys
by userby user[ad_1] Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys…
-
STOCK MARKET
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK
by userby user[ad_1] UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of…
-
STOCK MARKET
Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a $2.5 billion deal
by userby user[ad_1] Shares of Bausch + Lomb Corp. leapt into record territory Friday, after the eye-health…
-
[ad_1] Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary…
-
[ad_1] Novartis AG said Monday that a trial to evaluate prostate-cancer drug Pluvicto met its…
-
[ad_1] Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug…
-
[ad_1] Novartis AG said Thursday that Swiss competition-authority officers visited the company’s headquarters as part…
-
[ad_1] Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it…